🕵️ Palvella Therapeutics, Inc. ($PVLA)
SEC insider & ownership activity, last 12 months · CIK 1583648 · every row links its SEC filing
Over the last 12 months insiders sold $4.2M against $850K of open-market buying. Goin Kathleen sold $4.2M through a program of 9 sale notices averaging $468K (Nov–Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $850K (3 lots) · 1 seller, $4.2M (25 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Goin Kathleen | 0 | – | 25 | $4.2M | Jul 15, 2026 |
| George M. Jenkins | 2 | $550K | 0 | – | Mar 30, 2026 |
| Elaine J. Heron | 1 | $300K | 0 | – | Feb 27, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 7.5% | 13G | Feb 17, 2026 | filing ↗ | |
| Mathew P. Arens | 7.5% | 13G | Feb 17, 2026 | filing ↗ | |
| Suvretta Capital Management, LLC | 7.4% | 13G | Nov 13, 2025 | filing ↗ | |
| Aaron Cowen | 7.4% | 13G | Nov 13, 2025 | filing ↗ | |
| BVF Partners L P/IL | 7.1% | 13G | Feb 17, 2026 | filing ↗ | |
| BVF INC/IL | 7.1% | 13G | Feb 17, 2026 | filing ↗ | |
| Mark N. Lampert | 7.1% | 13G | Feb 17, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 6.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Averill Master Fund, Ltd. | 6.5% | 13G | Nov 13, 2025 | filing ↗ | |
| Frazier Life Sciences Public Fund, L.P. | 6.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Fhmlsp, L.P. | 6.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Fhmlsp, L.L.C. | 6.0% | 13G | Feb 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Goin Kathleen | $644K | Jul 15, 2026 | filing ↗ |
| Goin Kathleen | $476K | Jun 17, 2026 | filing ↗ |
| Goin Kathleen | $476K | May 20, 2026 | filing ↗ |
| Goin Kathleen | $557K | Apr 15, 2026 | filing ↗ |
| Goin Kathleen | $520K | Mar 18, 2026 | filing ↗ |
| Goin Kathleen | $345K | Feb 18, 2026 | filing ↗ |
| Goin Kathleen | $422K | Jan 21, 2026 | filing ↗ |
| Goin Kathleen | $416K | Dec 17, 2025 | filing ↗ |
| Goin Kathleen | $357K | Nov 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Other events (8.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Other events (8.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 13, 2026 | filing ↗ |
| Other events (8.01) | Apr 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Other events (8.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Other events (8.01) | Jan 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 29, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |